| Quarterly Financials | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 12 | 14 | 12 | 15 | 13 | 16 | 15 | 15 | 16 | 17 | 15 | 18 | 22 | 19 | 19 | 20 | 40 | 33 | 35 | 36 | 42 | 41 | 37 | 33 | 35 | 43 | 31 | 37 | 35 | 44 | 46 | 40 | 44 | 40 | 40 | 37 | 47 |
| Expenses | 11 | 12 | 11 | 13 | 11 | 14 | 13 | 13 | 14 | 15 | 13 | 15 | 18 | 16 | 16 | 17 | 21 | 22 | 25 | 29 | 27 | 30 | 28 | 26 | 27 | 31 | 26 | 30 | 27 | 35 | 35 | 33 | 35 | 32 | 33 | 31 | 38 |
| EBITDA | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 5 | 3 | 4 | 3 | 19 | 11 | 10 | 7 | 15 | 11 | 9 | 8 | 8 | 11 | 4 | 7 | 8 | 9 | 11 | 8 | 9 | 8 | 6 | 6 | 10 |
| Operating Profit % | 9 % | 7 % | 13 % | 11 % | 12 % | 13 % | 13 % | 9 % | 14 % | 15 % | 15 % | 11 % | 21 % | 14 % | 17 % | 16 % | 46 % | 33 % | 28 % | 19 % | 35 % | 26 % | 24 % | 23 % | 23 % | 25 % | 14 % | 19 % | 23 % | 20 % | 23 % | 18 % | 19 % | 19 % | 13 % | 13 % | 19 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 4 | 2 | 3 | 2 | 18 | 10 | 9 | 6 | 14 | 10 | 8 | 7 | 8 | 11 | 4 | 6 | 7 | 8 | 10 | 6 | 8 | 7 | 5 | 5 | 8 |
| Tax | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 4 | 3 | 2 | 2 | 4 | 2 | 2 | 2 | 0 | 1 | 0 | 1 | 1 | 2 | 3 | 1 | 1 | 0 | 1 | 1 | 1 |
| Net Profit | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 13 | 8 | 7 | 4 | 10 | 8 | 6 | 5 | 8 | 9 | 3 | 5 | 6 | 7 | 7 | 5 | 6 | 7 | 4 | 4 | 7 |
| EPS in ₹ | 0.58 | 0.72 | 0.37 | 1.14 | 0.79 | 0.51 | 1.00 | 1.05 | 1.12 | 1.41 | 1.10 | 0.80 | 2.37 | 1.72 | 2.13 | 2.33 | 15.42 | 8.72 | 8.02 | 4.55 | 10.56 | 7.74 | 6.33 | 6.03 | 9.08 | 11.04 | 3.95 | 6.07 | 7.47 | 7.89 | 8.68 | 6.05 | 7.74 | 8.10 | 5.31 | 4.90 | 8.30 |
Titan Biotech
Titan Biotech
939.45
+44.55
(4.98%)
Market Cap
776.31 Cr
EPS
26.06
PE Ratio
33.62
Dividend Yield
0.22 %
Industry
Chemicals52 Week High
1,017.85
52 Week Low
373.65
PB Ratio
4.82
Debt to Equity
0.04
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Titan Biotech Limited approved its unaudited financial results for the quarter ended June 30, 2025. The company reported standalone revenue of Rs. 4,649.64 lakhs compared to Rs. 4,311.46 lakhs in the same quarter last year. Net profit increased significantly to Rs. 616.08 lakhs from Rs. 569.96 lakhs year-over-year. Earnings per share improved to Rs. 7.46 from Rs. 6.90 in the previous quarter. The Board appointed Debendra Kumar Sabat as Additional Independent Director effective August 13, 2025. Two Managing Directors, Naresh Kumar Singla and Suresh Chand Singla, were reappointed for five-year terms from April 1, 2026 to March 31, 2031, subject to shareholder approval. The company scheduled its 33rd Annual General Meeting for September 26, 2025, via video conferencing, with a record date of September 19, 2025 for dividend payment of Rs. 2.00 per share.
Titan Biotech Faces Arbitration Notice for Rs. 10.62 Lakh Outstanding DuesJul 24, 2025
Titan Biotech Limited received an arbitration notice from NGenious Solutions Private Limited seeking recovery of disputed outstanding dues totaling Rs. 10,62,410 plus GST. The claim comprises balance outstanding of Rs. 9,13,920, compounded interest of Rs. 98,490 calculated till July 15, 2025, and compensation of Rs. 50,000 (all amounts excluding GST). The arbitration proceedings are filed against Titan Biotech Limited, its directors, and key management personnel. The company disclosed this as material litigation and stated that further developments will be communicated in due course.
Titan Biotech Reports Decline in Q3 EBITDA and MarginFeb 12, 2025
Titan Biotech's third-quarter financial results show a significant decrease in EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) from 106 million rupees to 49 million rupees year-over-year. The company's EBITDA margin also dropped from 23.03% to 12.67% compared to the same period last year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,054.20 | #1 1,55,351.50 | 70.78 | 13,387.50 | 6.91 | #1 2,096 | 18.69 | 47.74 | |
2,937.50 | 87,074.79 | 61.08 | 14,825.80 | 12.13 | 1,251 | 71.41 | 50.67 | |
3,713.60 | 40,793.90 | 65.15 | 4,853.20 | -25.09 | 546 | 70.37 | 62.35 | |
1,814.90 | 24,753.97 | 41.44 | 8,365.80 | 7.84 | 697 | -44.54 | 61.20 | |
4,894.30 | 24,262.83 | 71.75 | 2,393.10 | 12.83 | 289 | #1 128.91 | 58.26 | |
4,646.40 | 20,112.24 | 51.89 | #1 15,339.40 | 10.81 | 479 | -37.72 | 51.07 | |
6,545.00 | 19,269.63 | 38.56 | 5,692.40 | #1 18.99 | 499 | 18.11 | 54.93 | |
1,718.40 | 17,813.90 | 41.47 | 2,292.50 | 18.24 | 405 | 23.75 | 44.82 | |
4,880.80 | 14,964.52 | #1 36.76 | 2,366.70 | 7.83 | 411 | 3.35 | 54.40 | |
390.90 | 14,170.91 | 60.24 | 7,285.40 | 14.16 | 331 | -68.61 | 48.78 |
Forecast
Actual
Growth Rate
Revenue Growth
13.64 %
Net Income Growth
12.86 %
Cash Flow Change
-4.87 %
ROE
-7.32 %
ROCE
-5.89 %
EBITDA Margin (Avg.)
0.79 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 34 | 40 | 52 | 57 | 65 | 76 | 101 | 108 | 135 | 157 | 175 |
| Fixed Assets | 11 | 11 | 13 | 14 | 29 | 31 | 34 | 35 | 36 | 52 | 57 |
| Current Assets | 21 | 24 | 30 | 29 | 35 | 44 | 59 | 64 | 68 | 73 | 79 |
| Capital Work in Progress | 1 | 5 | 9 | 13 | 0 | 0 | 0 | 4 | 13 | 3 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 15 | 28 | 33 |
| Other Assets | 22 | 24 | 30 | 30 | 36 | 45 | 67 | 65 | 70 | 74 | 83 |
| Total Liabilities | 34 | 40 | 52 | 57 | 65 | 76 | 101 | 108 | 135 | 157 | 175 |
| Current Liabilities | 11 | 13 | 12 | 11 | 16 | 20 | 19 | 17 | 20 | 20 | 18 |
| Non Current Liabilities | 3 | 5 | 16 | 20 | 15 | 14 | 9 | 5 | 4 | 4 | 4 |
| Total Equity | 21 | 23 | 24 | 26 | 34 | 42 | 73 | 86 | 110 | 134 | 153 |
| Reserve & Surplus | 13 | 14 | 15 | 17 | 24 | 31 | 61 | 78 | 102 | 125 | 145 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 2 | 1 | -3 | 1 | 0 | 4 | 2 | -2 | -2 | 2 |
| Investing Activities | -3 | -5 | -8 | -6 | -4 | -2 | -5 | -16 | -21 | -20 | -10 |
| Operating Activities | -2 | 5 | 0 | 2 | 6 | 6 | 19 | 22 | 21 | 21 | 20 |
| Financing Activities | 3 | 2 | 9 | 0 | -0 | -4 | -11 | -4 | -2 | -3 | -8 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % | 55.88 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.23 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.03 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 34.79 % | 34.13 % | 36.44 % | 32.04 % | 31.71 % | 32.37 % | 32.25 % | 31.82 % | 31.82 % | 31.53 % | 31.44 % | 30.12 % | 30.06 % | 30.11 % | 29.97 % | 29.43 % | 29.20 % | 29.44 % |
| Others | 9.33 % | 9.99 % | 7.69 % | 12.09 % | 12.42 % | 11.75 % | 11.87 % | 12.30 % | 12.31 % | 12.59 % | 12.68 % | 14.00 % | 13.84 % | 14.01 % | 14.15 % | 14.69 % | 14.91 % | 14.65 % |
| No of Share Holders | 13,086 | 15,263 | 20,841 | 19,680 | 20,097 | 20,231 | 20,264 | 18,866 | 18,752 | 18,106 | 17,455 | 15,756 | 15,876 | 15,850 | 15,700 | 16,038 | 16,370 | 16,328 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.75 | 0.75 | 0.00 | 1 | 1.5 | 1.5 | 1.8 | 2 | 2 |
| Dividend Yield (%) | 0.00 | 1.19 | 1.67 | 0.00 | 0.54 | 0.57 | 0.76 | 0.34 | 0.47 | 0.22 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Sept 2025 |  Annual General Meeting | NA | 26 Sept 2025 | 436.85 | 894.90 |
| 19 Sept 2025 |  Dividend | ₹ 2.00 /share | 19 Sept 2025 | 457.50 | 894.90 |
| 08 Sept 2021 | Dividend | ₹ 1.50 /share | 16 Sept 2021 | 394.45 | 334.40 |
| 23 Sept 2022 | Dividend | ₹ 1.50 /share | 22 Sept 2022 | 229.75 | 242.35 |
| 22 Sept 2023 | Dividend | ₹ 1.80 /share | 22 Sept 2023 | 244.65 | 347.10 |
| 24 Sept 2024 | Dividend | ₹ 2.00 /share | 23 Sept 2024 | 587.65 | 673.65 |
| 30 Sept 2024 | Annual General Meeting | NA | 30 Sept 2024 | 584.25 | 667.60 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 922.25 | 877.35 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 726.50 | 674.95 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 455.00 | 457.50 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 427.05 | 436.85 |
Announcements
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015
Sep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Sep 02, 2025Weblink To Access Annual Report 2024-25 And Notice Of 33Rd AGM
Aug 30, 2025
Aug 30, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Aug 30, 2025
Aug 30, 2025Notice Of Thirty- Third (33Rd) Annual General MeetingAug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Revised Intimation For Book Closure Start DateAug 25, 2025
Aug 25, 2025Revised Intimation Of AGM Date Record Date And Book ClosureAug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Fixation Of Annual General Meeting Date Record Date Book Closure Date And E-Voting DateAug 13, 2025
Aug 13, 2025Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2024-25Aug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 13, 2025
Aug 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2025Aug 13, 2025
Aug 13, 2025Unaudited Financial Results For Quarter Ended June 2025Aug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Aug 01, 2025
Aug 01, 2025Announcement On Legal Notice Invoking Arbitration In A Disputed MatterJul 25, 2025
Jul 25, 2025Announcement Regarding Receipt Of Legal Notice Invoking Arbitration In A Disputed Matter.Jul 24, 2025
Jul 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 05, 2025
Jul 05, 2025Closure of Trading WindowJun 21, 2025
Jun 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
May 31, 2025Corporate Action-Board to consider DividendMay 30, 2025
May 30, 2025Appointment Of Internal AuditorMay 30, 2025
May 30, 2025Appointment Of Cost AuditorMay 30, 2025
May 30, 2025Appointment Of Secretarial AuditorMay 30, 2025
May 30, 2025Results_Audited Financial Results For The Quarter And Year Ended March 31 2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2025
May 26, 2025Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31 2025 And Consideration Of Recommendation Of Final Dividend If Any For The Financial Year EMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Appointment Of Secretarial Auditor For The Financial Year Ended On 31/03/2025Mar 24, 2025
Mar 24, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 28, 2025
Feb 28, 2025Integrated Filing (Financial)Feb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Feb 13, 2025Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial ResultFeb 12, 2025
Feb 12, 2025Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial ResultFeb 12, 2025
Feb 12, 2025Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December 2024Feb 12, 2025
Feb 12, 2025Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Financial Results For Quarter Ending On 31St December 2024Feb 03, 2025
Feb 03, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Jan 10, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 17, 2024
Dec 17, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 10, 2024
Dec 10, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 05, 2024
Dec 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 02, 2024
Dec 02, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 16, 2024
Nov 16, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2024
Nov 13, 2024Unaudited Financial Results For 3 Months Ended 30Th September 2024Nov 12, 2024
Nov 12, 2024Technical Indicators
RSI(14)
Overbought 81.27
ATR(14)
Less Volatile 43.35
STOCH(9,6)
Overbought 82.99
STOCH RSI(14)
Neutral 63.29
MACD(12,26)
Bullish 17.94
ADX(14)
Strong Trend 42.62
UO(9)
Bearish 79.98
ROC(12)
Uptrend And Accelerating 19.49
WillR(14)
Overbought 0.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
